Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

被引：25

作者：

Di Maio, Velia Chiara ^{[1
]}

Cento, Valeria ^{[1
]}

Aragri, Marianna ^{[1
]}

Paolucci, Stefania ^{[2
]}

Pollicino, Teresa ^{[3
]}

Coppola, Nicola ^{[4
]}

Bruzzone, Bianca ^{[5
]}

Ghisetti, Valeria ^{[6
]}

Zazzi, Maurizio ^{[7
]}

Brunetto, Maurizia ^{[8
,9
]}

Bertoli, Ada ^{[1
]}

Barbaliscia, Silvia ^{[1
]}

Galli, Silvia ^{[10
]}

Gennari, William ^{[11
]}

Baldanti, Fausto ^{[2
]}

Raimondo, Giovanni ^{[3
]}

Perno, Carlo Federico ^{[1
]}

Ceccherini-Silberstein, Francesca ^{[1
]}

VIRONET-C, Treatment Team H. C. V. Virology Italian Resistance Network

机构：

[1] Univ Roma Tor Vergata, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy

[2] Policlin Fdn San Matteo, Mol Virol, Pavia, Italy

[3] Univ Hosp Messina, Dept Internal Med, Messina, Italy

[4] Univ Campania Luigi Vanvitelli, Infect Dis & Viral Hepatitis Unit, Naples, Italy

[5] IRCCS AOU San Martino IST, Hyg Unit, Genoa, Italy

[6] Amedeo Savoia Hosp, ASL Citta Torino, Lab Microbiol & Virol, Turin, Italy

[7] Siena Univ Hosp, Virol, Siena, Italy

[8] Univ Hosp Pisa, Hepatol Unit, Pisa, Italy

[9] Univ Hosp Pisa, Lab Mol Genet & Pathol Hepatitis Viruses, Pisa, Italy

[10] St Orsola Malpighi Hosp Bologna, Microbiol & Virol Unit, Bologna, Italy

[11] Univ Hosp, Microbiol Lab, Modena, Italy

来源：

JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 03期

关键词：

DRUGS;

D O I：

10.1016/j.jhep.2017.09.008

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：597 / 600

页数：5

共 9 条

[1] The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution [J].

Cento, V. ;

Barbaliscia, S. ;

Di Maio, V. C. ;

Masetti, C. ;

Minichini, C. ;

Magni, C. F. ;

Micheli, V. ;

Marenco, S. ;

Nicolini, L. A. ;

Bruzzone, B. ;

Troshina, Y. ;

Baiguera, C. ;

Dentone, C. ;

Calvaruso, V. ;

Paolucci, S. ;

Melis, M. ;

Aragri, M. ;

Bertoli, A. ;

Lenci, I. ;

Landonio, S. ;

Schiavini, M. ;

Sticchi, L. ;

Ruggiero, T. ;

Polilli, E. ;

Messina, V. ;

Pellicelli, A. ;

Boglione, L. ;

Cozzolongo, R. ;

Biolato, M. ;

Morisco, F. ;

Siciliano, M. ;

Parruti, G. ;

Barbarini, G. ;

Craxi, A. ;

Babudieri, S. ;

Puoti, M. ;

Ciancio, A. ;

Rizzardini, G. ;

Coppola, N. ;

Angelico, M. ;

Perno, C. F. ;

Ceccherini-Silberstein, F. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S744-S745

[2]

Cento V, 2017, C RETR OPP INF CROI

[3] EASL Recommendations on Treatment of Hepatitis C 2016 [J].

European Association for the Study of the Liver easloffice@easloffice.eu .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :153-194

[4] New findings in HCV genotype distribution in selected West European, Russian and Israeli regions [J].

Kartashev, Vladimir ;

Doering, Matthias ;

Nieto, Leonardo ;

Coletta, Eleda ;

Kaiser, Rolf ;

Sierra, Saleta .

JOURNAL OF CLINICAL VIROLOGY, 2016, 81 :82-89

[5] Hepatitis C virus drug resistance-associated substitutions: State of the art summary [J].

Lontok, Erik ;

Harrington, Patrick ;

Howe, Anita ;

Kieffer, Tara ;

Lennerstrand, Johan ;

Lenz, Oliver ;

McPhee, Fiona ;

Mo, Hongmei ;

Parkin, Neil ;

Pilot-Matias, Tami ;

Miller, Veronica .

HEPATOLOGY, 2015, 62 (05) :1623-1632

[6] Hepatitis C Drugs: Is Next Generation the Last Generation? [J].

Pawlotsky, Jean-Michel .

GASTROENTEROLOGY, 2016, 151 (04) :587-590

[7] MAGELLAN-1, Part 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic hepatitis C virus genotype 1 or 4 and prior direct-acting antiviral treatment failure [J].

Poordad, F. ;

Pol, S. ;

Asatryan, A. ;

Buti, M. ;

Shaw, D. ;

Hezode, C. ;

Lalezari, J. ;

Felizarta, F. ;

Reindollar, R. W. ;

Gordon, S. C. ;

Pianko, S. ;

Fried, M. W. ;

Bernstein, D. E. ;

Gallant, J. ;

Lin, C. -W. ;

Lei, Y. ;

Ng, T. I. ;

Pilot-Matias, T. ;

Kort, J. ;

Mensa, F. .

JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S83-S84

[8] The importance of resistance to direct antiviral drugs in HCV infection in clinical practice [J].

Sarrazin, Christoph .

JOURNAL OF HEPATOLOGY, 2016, 64 (02) :486-504

[9] Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses [J].

Welzel, Tania M. ;

Bhardwaj, Neeru ;

Hedskog, Charlotte ;

Chodavarapu, Krishna ;

Camus, Gregory ;

McNally, John ;

Brainard, Diana ;

Miller, Michael D. ;

Mo, Hongmei ;

Svarovskaia, Evguenia ;

Jacobson, Ira ;

Zeuzem, Stefan ;

Agarwal, Kosh .

JOURNAL OF HEPATOLOGY, 2017, 67 (02) :224-236

← 1 →